• Corpus ID: 23419389

Intracerebroventricular endothelin-1 (ET-1) produces Ca(2+)-mediated antinociception in mice.

  title={Intracerebroventricular endothelin-1 (ET-1) produces Ca(2+)-mediated antinociception in mice.},
  author={Rumen Nikolov and J E Maslarova and Irina Semkova and Slavianka G Moyanova},
  journal={Methods and findings in experimental and clinical pharmacology},
  volume={14 3},
Intracerebroventricular (i.c.v.) administration of endothelin-1 (ET-1) at doses of 0.313, 0.625, 1.25, 2.5 and 5 pmol/mouse produced a strong antinociceptive effect as evaluated by hot plate method in mice. The effect was dose-dependent and lasted for more than 120 min. The opioid receptor antagonist naloxone did not antagonize, and the cyclooxygenase inhibitors indomethacin and diclofenac slightly inhibited the ET-1 effect. The calcium overload blocker cinnarizine antagonized the… 
Endothelin-1 in periaqueductal gray area of mice induces analgesia via glutamatergic receptors
It is suggested that the activation of NMDA glutamatergic receptors in the PAG area may be a necessary step for ET‐1 induced antinociception.
Selective and non-selective ET antagonists reveal an ET(A)/ET(B) receptor mediated ET-1-induced antinociceptive effect in PAG area of mice.
Since ET-antagonists lowered per se the control reaction time of the mice when administered alone to the PAG area, it is suggested that endogenous ET-1 acting within the P AG area contributes to the suppression of pain.
The receptors for endothelins and their analogues in SK-N-MC neuroblastoma cells
The potency order of peptides to inhibit [125I]endothelin-1 binding and to stimulate phosphatidylinositol phosphate (PtdInsP) turnover in SK-N-MC cells was consistent with the presence of ETA- endothelin receptors, suggesting metal ions may directly interact with endothelins receptors.
Title Effects of Repeated Central Administration of Endothelin Type A Receptor Antagonist on the Development of Neuropathic Pain in Rats
Endothelin-1 (ET-1) predominates in the endothelin family effectively in vascular tone control, mitogenesis, and neuromodulation. Its receptors are widespread in the central nervous system (CNS)
Effects of Repeated Central Administration of Endothelin Type A Receptor Antagonist on the Development of Neuropathic Pain in Rats
The results provide insight into the therapeutic strategies, including timing, against neuropathic pain development with ETAR antagonist in a sciatic nerve ligation (SNL) animal model and show the most stable and significant mechanical threshold rise.
Role of central endothelin-1 in hyperalgesia, anhedonia, and hypolocomotion induced by endotoxin in male rats
Results indicate that ET-1 and both ET A and ET B receptors are involved in various responses that are related to sickness syndrome, including hyperalgesia, anhedonia, and hypolocomotion, that is induced by LPS.
Over-expression of astrocytic ET-1 attenuates neuropathic pain by inhibition of ERK1/2 and Akt(s) via activation of ETA receptor
The results showed that the xover-expression of astrocytic ET-1 reduced SNL-induced allodynia and hyperalgesia by inhibiting the activation of ERK1/2 and Akt via the ETA-R-mediated pathway.
Over-expression of endothelin-1 in astrocytes, but not endothelial cells, ameliorates inflammatory pain response after formalin injection.
The current results support a suppressor role for astrocyte-derived ET-1 in inflammatory pain and suggest that the study of GET-1 mice might provide mechanistic insights for improving the treatment of inflammatory pain.
Intrathecal endothelin-1 has antinociceptive effects in rat model of postoperative pain.
The results show that the pain threshold, which is decreased by surgical stimuli, is partially restored by intrathecal endothelin-1 through both endothelins ET(A)- and ET(B)- receptors in DRG neurons and microglia in the spinal cord.
Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole.
Results indicate that sulfisoxazole, an ETA receptor antagonist, potentiates the analgesic effect of clonidine, which could be mediated through I1-imidazoline receptors and opioid receptors.